Remission of Acromegaly after transsphenoidal surgery: A case report

Joel Rudy Ekoundzola *, Hanan Boualam, Sana Rafi, Ghizlane El Mghari and Nawal El Ansari

Department of Endocrinology, Diabetes, Metabolic Diseases and Nutrition, Mohammed VI University Hospital, Marrakesh, Morocco.
 
Case Study
World Journal of Advanced Research and Reviews, 2023, 18(01), 618–621
Article DOI10.30574/wjarr.2023.18.1.0652
 
Publication history: 
Received on 06 February 2023; revised on 12 April 2023; accepted on 14 April 2023
 
Abstract: 
Acromegaly is a rare, chronic disorder that mostly results from growth hormone (GH)-secreting pituitary adenoma. It is a rare neuroendocrine condition that can lead to significant morbidity. Transsphenoidal surgery is the first-line treatment of this adenoma. We report a case of recovery from acromegaly after post transsphenoidal surgery.
 
Keywords: 
Acromegaly; Growth Hormone; Insulin-Like Growth Factor 1; Pituitary, Remission.
 
Full text article in PDF: 
Share this